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Abstract: The epitome of the One Health paradigm—and of its shortcomings—rabies has been known
to humankind for at least 4000 years. We review the evolution through history of concepts leading
to our current understanding of rabies in dogs and humans and its prevention, as transmitted by
accessible and surviving written texts. The tools and concepts currently available to control rabies
were developed at the end of the 19th Century, including the first live, attenuated vaccine ever
developed for humans and the first post-exposure prophylaxis (PEP) regimen. No progress, however,
has been made in etiological treatment, leaving clinicians who provide care to animals or patients
with symptomatic rabies as powerless today as their colleagues in Mesopotamia, 40 centuries ago.
Rabies remains to date the most lethal infectious disease known to humans. Widespread access to
timely, effective, and affordable PEP in rural areas of developing countries is urgently needed.
Keywords: rabies; vaccine; history; One Health; post-exposure prophylaxis; Galtier; Roux; Pasteur;
Semple; dog
Preamble
Rabies is an ancient and much-feared disease. Over the centuries, many different authors—clinicians,
veterinarians, surgeons, pharmacists but also writers, philosophers, and poets—have mentioned rabies in their
writings. The sequence of research and surviving writings on rabies described below is far from exhaustive.
Rather, it aims to identify the work of those who made remarkable contributions to the current stage of knowledge
on dog-mediated rabies, its cause and its prevention, control or management. Sources that conducted research on
rabies but proposed alternate views of causation now considered misleading (such as spontaneous generation) have
purposefully been left aside. Furthermore, no further potential sources from Ancient China, India, pre-Columbian
America, or Africa could be identified or accessed.
1. Rabies in Sumerian and Akkadian Civilizations
Humans have lived alongside domesticated dogs for 14,000 years at least, with estimates reaching
back to 32,000 years [1,2]. They have also long been familiar with their diseases, which became more
prevalent as populations and their animals congregated in the cities that arose in Mesopotamia [3–6].
Two cuneiform tablets (Figure 1) discovered at Tell Abu¯ Harmal, Baghdad Governorate, Iraq in 1945
and 1947, recount the Laws of Eshnunna, a Sumerian and later Akkadian city-state located in present
Tell Asmar, Iraq [7]. This city was most prominent during the Isin-Larsa period, ca. 1950–1850 BCE
and the tablet is dated ca. 1770 BCE [8]. Distinct copies of another source date back to ca. 1930 BCE.
These describe Sumerian rules and regulations attesting to the fact that a causal link between the bite
of a rabid animal and a human death from rabies was well recognized almost 4000 years ago [9]:
Trop. Med. Infect. Dis. 2017, 2, 5; doi:10.3390/tropicalmed2020005 www.mdpi.com/journal/tropicalmed
Trop. Med. Infect. Dis. 2017, 2, 5 2 of 21
Trop. Med. Infect. Dis. 2017, 2, 5  2 of 21 
 
causal link between the bite of a rabid animal and a human death from rabies was well recognized 
almost 4000 years ago [9]:  
 
“If a dog becomes rabid and the ward authority makes that known to its 
owner, but he does not watch over his dog so that it bites a man and 
causes his death, the owner of the dog shall pay forty shekels of silver; if 
it bites a slave and causes his death, he shall pay fifteen shekels of silver.” 
(a) (b)
Figure 1. Excerpts from the Sumerian Laws of Eshnunna, Northern Babylonia ca. 1930 BCE. (a) Tablets 
of the Laws of Eshnunna; (b) One possible translation of Paragraphs 56–57 of the Laws of Eshnunna 
(A iv 20–24) [10]. Another possible translation speaks of a dog becoming “furious” or “vicious” [8,9]. 
Even 15 shekels was a considerable sum: The Hammurabi code mentions the cost of a boat of sixty 
"gur" at two shekels. (Source: http://legacy.fordham.edu/halsall/ancient/hamcode.asp). 
Acknowledgement: Dr. Mark Weeden, Lecturer in Ancient Near Eastern Studies, School of Oriental 
and African Studies, London, UK. 
At least five old Mesopotamian “dog incantations” (ca. 1900–1600 BCE) such as the one below 
(Figure 2) clearly reflect the notion of rabies being caused by something present in the saliva of the 
afflicted animal, akin to the poison transmitted by a snakebite or scorpion sting [9–12]. An herb seems 
to have been used after a dog bite and the biting dog’s movement was restricted [12]. Dogs were 
thought more likely to become rabid when a lunar eclipse occurred at year’s end [9].  
 
"Its [seed] coagulates on its [dogs’] teeth. 
Where it has bitten it has left its [consequence].” 
(a) (b)
Figure 2. “Dog incantation”, ca. 1900–1600 BCE (a) Tablet; (b) Translation, adapted from [11]. 
Finally, clay tablets (Figure 3) unearthed by H.V. Hilprecht in 1889 at the Nippur site (3rd 
dynasty of Ur III, 21st- 20th-century BCE) of what is now Nuffar in Iraq display Akkadian 
incantations, to which healers resorted when medicine failed [9,13,14]. This dialogue between 
Marduk, the God of Healing, and his father Enki was recited by priests over (thus blessed) water 
Figure 1. Excerpts from the Sumerian Laws of Eshnunna, Northern Babylonia ca. 1930 BCE. (a) Tablets
of the Laws of Eshnunna; (b) One possible translation of Paragraphs 56–57 of the Laws of Eshnunna
(A iv 20–24) [10]. Another possible translation speaks of a dog becoming “furious” or “vicious” [8,9]. Even
15 shekels was a considerable sum: The Hammurabi code mentions the cost of a boat of sixty “gur” at
two shekels. (Source: http://legacy.fordham.edu/halsall/ancient/hamcode.asp). Acknowledgement:
Dr. Mark Weeden, Lecturer in Ancient Near Eastern Studies, School of Oriental and African Studies,
London, UK.
At l ast five old Mesopotamian “dog incantation ” (ca. 1900–1600 BCE) such as the one below
(Figure 2) clearly reflect t n ti of rabies being caus d by somethi g present in the saliva of the
afflicted animal, akin to the poison tra smitted by a snakebite or scorpion sting [9–12]. An herb seems
to have been used after a dog bite and the biting dog’s movement was restricted [12]. Dogs were
thought more likely to become rabid when a lunar eclipse occurred at year’s end [9].
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Figure 2. “Dog incantation”, ca. 1900–1600 BCE (a) Tablet; (b) Translation, adapted from [11].
Finally, clay tablets (Figure 3) unearthed by H.V. Hilprecht in 1889 at the Nipp r site (3rd dynasty
of Ur III, 21st- 20th-century BCE) of what is nowNuffar in Iraq display Akkadian incantations, to which
healers resorted when medicine failed [9,13,14]. This dialogue between Marduk, the God of Healing,
and his father Enki was recited by priests over (thus blessed) water which was then administered orally.
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These incantations are striking, marked as they are by the caveat of likely—however divine—failure,
and certain death should rabies develop.
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“Oh! my Father! Concerning a man whom a […] 
rabid dog attacks, and to whom it passes (lit. 
"gives") its venom […], I do not know what shall I 
do for that man.” 
"Oh! my son! For what you do not know, what can 
I add for him?" 
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Figure 3. Ur incantations. (a) Tablets of the Ur III incantations (http://cdli.ucla.edu/P142047); (b) 
Translation. Acknowledgement: Prof. N. Veldhuis, Professor of Assyriology, University of California, 
Berkeley, CA, USA. 
Just like Yama, a Hindu god of death, the Babylonian Goddess Gula, patroness of doctors and a 
healing deity, was represented in the 14th–7thC BCE with a dog at her feet [15,16] (Figure 4). In one 
ancient tale, a Nippur man bitten by a dog, self-referred for treatment to a temple in Isin, the city of 
Gula [9]. As ancient deities of the Near East were shown mounting or otherwise dominating animals 
to demonstrate their power, it can be hypothesized that this association represented dogs both 
positively (the dog as a protector) and negatively (the dog as a source of danger, including rabies) 
(Prof. T. Ornan, personal communication, 11 December 2015).  
 
Figure 4. Goddess Gula represented on her throne, a dog at her feet on a kudurru of Nebuchadnezzar 
I (12th Century, BCE) [16]. Acknowledgement: Prof. Tallay Ornan, Hebrew University of Jerusalem, 
Department of Archaeology & the Ancient Near East Department. 
Although this remains disputed [17], the origin of "rabias", the Latin word for rabies, may 
originate from "rabhas" or "rabhasa" (रभस) in Sanskrit (http://www.webcitation.org/6os2XRrN8), 
perhaps crossing Indo-European cultures and centuries [18]. Indeed, rabies is mentioned in many 
ancient texts, from the Vedic period (in ancient India ca. 1750–500 BCE) [19–21], to ancient China [22–
25], Egypt [26] and the Middle East [27] as well as Greece and Rome [19,28]. Attempts at prevention 
or treatment of clinical rabies, however, remained faith-based, magical or otherwise exotic [19,29–31]. 
Figure 3. Ur incantations. (a) Tablets of the Ur III incantations (http://cdli.ucla.edu/P142047);
(b) Translation. Acknowledgement: Prof. N. Veldhuis, Professor of Assyriology, University of California,
Berkeley, CA, USA.
Just like Yama, a Hindu god of death, the Babylonian Goddess Gula, patroness of doctors and a
healing deity, was represented in the 14th–7thC BCE with a dog at her feet [15,16] (Figure 4). In one
ancient tale, a Nippur man bitten by a dog, self-referred for treatment to a temple in Isin, the city of
Gula [9]. As ancient deities of the Near East were shown mounting or otherwise dominating animals to
demonstrate their power, it can be hypothesized that this association represented dogs both positively
(the dog as a protector) and negatively (the dog as a source of danger, including rabies) (Prof. T. Ornan,
personal communication, 11 December 2015).
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2. Rabies in Classical Antiquity
Aristotle, Hippocrates, Pliny, Ovid, Cicero... a great many texts by physicians and other authors
of classical antiquity attest to a progressively improved comprehension of rabies. They—and especially
Caelius Aurelianus, who also wrote an early description of palliative care in rabies patients [32]–provide
accurate and detailed descriptions of symptoms, whether in dogs or in humans [19,28,31,33,34]. Galen
noted the absence of symptoms in bite victims before the onset of rabies [34]. Both Dioscorides
(ca. 4–90 CE) and Philomenos (1stC CE) discuss a latency period of varying duration after an infective
bite, generally lasting six weeks but sometimes lasting up to several years [32]. In his “Emergency
Formulas to Keep up One’s Sleeves” (Zho˘u Hòu Jiù Zú Fa¯n,74&◆Ë), Ge Hong (dl) of the Jin
Dynasty (around 300 CE) also described prolonged incubation periods in humans (but unfortunately
recommended the application of the biting dog’s brain tissue to the bite wound to prevent rabies) [35].
Primary prevention of rabies through the prevention of bites by suspected rabid dogs was
recommended in the Persian Avesta, composed in 200–400 CE, perhaps from much more ancient
texts [36]. Around 60 CE, Columella’s De Re Rustica described shepherds’ habit of cutting puppies’
tails when they are 40 days old, as a preventive measure against rabies in dogs should they be bitten,
perhaps one of the earliest known example of One Health, or at least One Medicine, which sees
disease prevention in humans as intimately linked with the health of the animals to which they are
exposed [32,37–39]. Many different treatments were on offer to prevent rabies in dogs after they had
been bitten [40].
Rabies prevention after a bite in humans made few advances. Similar incantations to that found
at Nippur/Nuffar were spoken in Greek-speaking Egypt around the 3rdC CE [41]. Along with
Aulus Cornelius Celsus in his De Medicina (published between 18 and 39 CE in Rome) [42,43], the only
author who may have had some impact on the replication of viral inocula in wounds made by rabid
animals, was Pedianus Dioscorides (ca. 40–90 A.D.), of Anazarba in Cilicia, founded by the Assyrians
but a then Roman city, now in Adana Province of southern Turkey. A physician and a pharmacologist,
he is said to have described rabies accurately and like Celsus, proposed cauterization of the bitten part
as prevention [28]. But all attempts at treatment of clinically-declared rabies cases remained based on
hopeful conjecture [44] or were denounced as unnecessarily brutal, as by Asclepiades of Bithynia in
the mid-2ndC CE [45].
3. The Middle Ages
The list continues with great mediaeval practitioners of medicine and botany, in Europe
and elsewhere [19,28,31,33]. Despite religious antagonism against dogs, considered unclean,
and recommendations for their containment [40] the mediaeval Middle East was rife with stray
dogs [26,27,46]. Works by Mohammad-e Zakaria¯-ye Ra¯zi (Rhazes) [47,48], Ibn-Sı¯na¯ (Avicenna) [47,49],
Moshe ben Maimon a.k.a. Mu¯sa¯ ibn Maymu¯n (Maimonides) [27,29] and many others [32], all discuss
or refer to dog-mediated rabies (Figure 5). Authors continued to accurately describe the disease in
animals or humans, including the notion of paralytic rabies [40], the absence of hydrophobia in rabid
dogs [40], or of a—in some cases considerable—delay [29] before symptoms onset of rabies in humans
and its lamentable prognosis. No further remedy to clinically-declared rabies was identified.
At the end of the 13thC, Arnaldus de Villanova insisted on the importance of careful and thorough
wound cleansing as prevention of rabies after a dog bite [50]. Bartholomew Glanville (mid-13thC) is
said to have referred to a poison, “growing” and “multiplying” in bite wounds although this author
found no primary source [40]. Prevention and treatment otherwise made no significant progress.
Medical or surgical management delineated in Ancient Greece or Rome became increasingly tinted
with religion. In Europe a miracle cure was deemed to be found at several specialized religious
sites [51], such as the church of the village of Andage, renamed Saint-Hubert, where Louis I the
Pious, one of Charlemagne’s sons and his successor, authorized the transfer of the eponymous saint’s
thighbones in 826 CE. This abbey located near Liège, Belgium became a specialized center for rabies
prevention. At the time, prevention before a bite took the form of applying a white-hot Key of
Trop. Med. Infect. Dis. 2017, 2, 5 5 of 21
Saint Hubert to dogs so they would not contract the disease [52,53]. An example of this amulet
can be seen at http://www.webcitation.org/6os1x82Ty. Contrary to what was practiced in other
reputed sites such as San Bellino [17], near present-day Rovigo in Italy, or in Saint-Tügen’s chapel in
Primelin, France, this method must have been considered too cruel or too unreliable in humans bitten
by suspected rabid animals. In humans, the preferred method of rabies prevention after a bite was
based on incision of the forehead and implantation of threads from the Saint’s supposedly miraculous
stole, accompanied by prayers and fasting [19,25,52–54]. In spite of Ambroise Paré—who after the
siege of Turin in 1536 discontinued the practice of cauterization to heal wounds [55,56]—Dioscorides’
and Celsus’ cauterization approach remained widespread in the management of rabies risks well into
the 19thC [31,57]. This may be because cauterization was performed to inactivate a “poison” and
perhaps also because their work was never lost to practitioners in Europe in spite of the fall of the
Roman Empire [58,59]. Patients, however, found little recourse should prevention fail: at Saint-Tügen
chapel, patients with declared rabies were stifled between mattresses until the beginning of the 19thC.
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translation of the Materia medica by Dioscorides (ca. 40–90 C.E.) copied by Abdallah ibn al-Fadl,
Baghdad, A.H.621/1224 A.D. Freer Gallery of Art and Arthur M. Sackler Gallery, Smithsonian
Institution, Washington, D.C.: Purchase—Charles Lang Freer Endowment, F 1953.91.
4. After 1492: Emergence and Control
Rabies continued to concern populations and medical writers of the Renaissance. Julien Le Paulmier
(1520–1588) wrote seven medical textbooks in all, one specifically on rabies [60,61].
The preventive practices at Saint-Hubert were condemned by the Sorbonne as superstitious in
June 1671 [28] but remained in use in the Ardennes well into the 19thC [19,28,31,54]. The protective
effect of thorough wound washing, and described anew in a publication dated 1796 cited by
C. Ménécier, was by now well established among clinicians [62,63]. The converse was also true:
the potentially deadly role of saliva was put to use by Polish-Lithuanian artillery general Kazimierz
Siemienowicz (c. 1600–c. 1651), who in an early attempt at biological warfare, is said to have fired
hollow shells containing saliva of rabid dogs in 1650 [64,65].
“Madstones”—bezoars or gallstones–thought to absorb or otherwise neutralize the agent of rabies
were used extensively as amulets in mediaeval Europe and well into the 19thC by early European
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settlers in North America [31,66,67]. Dog-mediated rabies circulated in Europe, in Africa and in
Asia [26,31,68]. Human deaths associated with bat bites were already identified in the mid-1500s in
Latin America [69]. Although there were Nahuatl (Aztec) words for rabies and rabid dogs in what is
now central Mexico, canine rabies was noticeably rare if not entirely absent from Central and South
America [25,31,66,69]. Dog-mediated rabies, however, seems to have circulated more intensely and
widely in both the Old and the NewWorld after the landings of seafaring European conquerors and
their dogs [19,25,68,70,71]. The 18thC was marked by intense rabies epizootics in the Americas and by
the emergence of rabies on many islands of the Caribbean and the Indian Ocean [25,28,68,72]. Rabies
became rampant among mongooses introduced in the Caribbean to eliminate rats pillaging sugar
fields [73–76]. Colonial powers increasingly documented animal and human rabies cases in southern
Africa in the 18th–19th Centuries [77].
Although circulation of rabies had reportedly increased, especially in Europe, great progress was
being made in the prevention of dog bites in European cities [28,40]. Regulations for keeping dogs
or for the containment of domestic dogs and elimination of stray dogs were passed in a city (Utrecht,
Netherlands) in 1446 [78], in a Dutch province (Friesland) in 1714 [61], and in a country (Prussia)
in 1787 [72,79,80]. A similar approach led to the successful elimination of dog-mediated rabies from
Denmark, Norway and Sweden by 1826 [81]. Other long-known approaches including muzzling were
implemented in other cities or territories [28,40,72]. In a 1793 communication, Samuel Bardsley proposed
to quarantine local and imported dogs to “eradicate rabies from the British Isles” [40,82]. The decision to
implement an international plan to control canine rabies was made at the 2nd International Veterinary
Conference in Vienna on 21–27 August 1865. Cities and states legislated, integrating and applying
early forms of what are now termed One Health principles [20,53].
The understanding of the physiopathology of rabies also evolved: in 1546, Girolamo Fracastoro
hypothesized that rabies was transmitted by semina (“seeds”) present in the saliva [64,72,83,84].
Edward Topsell, translating Conrad Gessner’s work dated ca. 1555, mentions that rabies transmission
is inconstant after the bite of a rabid dog [17]. Martin Lister added in 1698 that the risk of transmission
varies according to the anatomical site of the bite [32], a notion comprehensively described by
John Hunter in 1793 [85]. Joseph-Ignace Guillotin proposed in 1766 that biting dogs remain in 15-day
observation to ascertain the risk of rabies transmission to a bite victim [40]. Van Swieten in 1775
declared saliva to be the source of rabies transmission and provides a clinical description in humans
that remains relevant to date [86]. Hunter also spoke of many animals being, like humans, susceptible
to rabies without being capable of transmitting the virus, and of that susceptibility being variable
among species [85]. In 1776 and 1793, respectively, both Guillotin and Hunter proposed (dog bite)
inoculation experiments to better understand the physiopathology of rabies, including in prisoners
awaiting capital punishment [24,85,87]. Like Pasteur’s similar considerations plainly laid out in a letter
to the Emperor of Brazil dated September 22, 1884, ten months before the post-exposure vaccination of
Joseph Meister, these fortunately were never put into effect [87,88].
The understanding of post-bite rabies prevention in animals or in humans, however, still made
no progress. Published on 17 June 1684, the first edition ofMedicina Curiosa, the first English-language
journal wholly dedicated to medicine, describes post-exposure prevention failure in a suspected human
case of rabies acquired from a cat [89]. “Treatment” after a bite remained faith-based [90] or otherwise
fanciful, based for example on applying hair of the biting dog (“hair of the dog”) to the wound [28,66]
or omelets flavored with “dog-rose root” (Rosa canina or cynorrhodon, as already suggested by Pliny
the Elder in the 1stC CE) [91–95]. The same was true outside Europe [96]. Suggested therapies—some
even based on homeopathic approaches—were rightly criticized as ineffective [97]. The fact that rabies
is not transmitted in all cases even after the bite of an evidently rabid dog or wolf contributed to the
illusion that each of the many preventive “treatments” had been effective.
These are all too easily disparaged as ludicrous recommendations made by self-assured and
pompous clinicians, steeped from old-wives’ remedies. They are, however, sure signs of desperate
and all-out efforts by health providers of the time to save their patients from what to this day remains
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an intractable disease. Vigorous approaches continued to be used well into the mid-19thC: In 1830s
London, children bitten by potentially rabid dogs still underwent surgery or cauterization of the
wound [57] (still discussed by Babes in 1912 [72]). Patients with clinically declared rabies were plunged
into cold water or hot oil as recommended by Celsus [31,86], or were later euthanized by being stifled
between mattresses or made to bleed to death [17,90,98,99].
5. Pasteur and His Time
Around the turn of the 19thC, the scientific approach improved the understanding of the
physiopathology and clinical epidemiology of rabies, which was remarkably summarized by Samuel
Cooper in 1823 [100].
Much experimental work was done on the transmission of rabies [26,101–103]—and its prevention
through the amputation (Helmann, cited in [72]) or immunization of animals [28,72,102,104]. In 1804
in Jena (in present-day Germany), Georg Zinke transmitted rabies experimentally (without a bite) by
applying the saliva of rabid dogs to animals’ tissues [28,31,101–103,105]. The same was demonstrated
in 1813 by Hugo Altgraf zu Salm-Reifferscheidt [106] and prior to 1814 by François Magendie and
Gilbert Breschet, this time using saliva from a human rabies patient [107–109]. In 1805 in Turin,
Francesco Rossi reported having experimentally transmitted rabies to dogs by inserting sciatic nerve
segments of rabid cats into a fresh wound [110]. Clinicians progressively identified the seat of rabies
infection in the midbrain [28,102] and nerve ending density was positively correlated with risks of
infection and migration [72,111].
In the struggle pitting the microbial theory against spontaneous generation, subsequent
experiments provided solid scientific evidence to support the long-suspected transmission of rabies
by “filterable” infectious agents present in the saliva [101,102,104]: Magendie in 1842 suspected that
the agent was not a poison but a “virus” capable of multiplying and developing in the host [112,113].
Magendie, then Casimir Davaine in 1872, experimented on virulence, increased by serial passage (but
these were with septicemia and anthrax bacteria, not with viruses) [114–116]. In 1880, Edmond Nocard
succeeded in separating saliva into two components, one non-infective and the other infective [117].
These agents were now considered to progressively ascend from the infected wound to the brain not
through the blood but through the nerves—as initially hypothesized in 1879 but not established by
Paul-Henri Duboué [118]—before diffusing centrifugally [31,72,102,112].
Resorting to nerve section as a means of prevention had been contemplated by George Hicks in
1807 [119]. Duboué—who communicated his findings to Louis Pasteur on 12 January 1881 [117]—also
postulated that the rabies “virus” could be destroyed in situ or prevented from reaching the medulla
oblongata [111]. This paved the way for the advent of post-exposure prophylaxis, based on the notion
of taking advantage of the latency period and rapidly building the patient’s immunity through timely
and adequate vaccination [102].
Variolation—the use of dried-out scabs containing attenuated smallpox virus to directly immunize
against and preventmore severe smallpox–had been performed by intranasal insufflation in China since
the 10thC, and inoculation was later extensively used in the Ottoman Empire [120,121]. This hazardous
procedure was described by Emanuele Timoni in 1714 and subsequently experimented by Hans
Sloane in English prisoners in 1722, after being championed by Mary Wortley Montagu [120–126].
Vaccination—the inoculation of virus causing much milder cowpox—to provide cross-immunization
against smallpox had been pioneered by Benjamin Jesty in 1774, Peter Plett in 1790–1792 and Edward
Jenner in 1796, perhaps based on John Fewster’s earlier work [121,127,128]. Putting John Hunter’s
recommendations into practice, Eusebio Valli, an Italian physician, claimed to have carried out
experimental infections and successfully immunized dogs by injecting the saliva of other dogs after
submitting it to gastric juices of frogs in 1799. He claimed to have inoculated this mixture to at least
two people in Pisa bitten by a suspected rabid dog and who did not contract rabies [24,129,130].
If confirmed, this would make Valli the initiator of the first attenuated vaccine and rabies vaccine,
although the small numbers discussed and the absence of laboratory confirmation would not prove
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preventive effectiveness. Valli in 1816 made a fatal attempt at self-inoculation, not with rabies virus but
with yellow fever, a few days after landing in Cuba to assist in an epidemic [26,131–133]. Although this
author was unable to access original sources, Apollinaire Bouchardat, a pharmacist of the Veterinary
Faculty in Lyons, is cited as having postulated in the 1850s that dogs could be immunized against
rabies as a public health measure [134]. Available sources from 1882–1884 show Bouchardat discussing
vaccination against infectious diseases, citing Pasteur’s work. In 1879, at the Veterinary school
also in Lyons, rabies pioneer Pierre-Victor Galtier inoculated rabies to a rabbit through cutaneous
injection, administered rabid dog saliva intravenously to a sheep which did not contract rabies but
became immunized, theorized post-exposure prophylaxis and began experimenting on vaccination of
dogs [102,135–144]. Henry Toussaint—another veterinarian—conducted research in Lyons on heat-
and subsequently carbolic acid-attenuated anthrax vaccine in 1880 [144,145]. Paul Gibier from the
Faculty of Medicine and the Muséum d’Histoire Naturelle de Paris, showed in 1883–1884 that the
rabies virus lost virulence after dessication and that this approach could be used in humans [146,147].
It is in this already extremely rich and advanced research context that Louis Pasteur and his
colleagues at the Ecole Normale Supérieure in Paris began to apply their systematic, rigorous and
data-driven scientific methods to the study of rabies in December of 1880 [92,118,146]. Pasteur and
his team had already developed an effective attenuated fowl cholera vaccine [148], were working
on an attenuated anthrax vaccine and strove to apply their techniques to rabies—a much-feared
and highly symbolic disease, albeit known to be controllable by veterinary measures alone [117,149].
An experimental model of rabies was developed by Paul Emilio (Emile) Roux in dogs inoculated
after trepanation, and later in the noticeably more manageable rabbit [92,102]. A “fixed”, adapted,
rabies virus strain of “exalted virulence” with shorter incubation times and unfailing transmission
could then be selected through successive passage in the rabbit, thereby paving the way for an
experimental and methodical approach. After discussing it in 1881 [150], Pasteur and his team
endeavored in 1882 to develop a canine “vaccine” (thus named in honor of Jenner), using after
1884 the desiccation technique also developed by Emile Roux to attenuate this live, highly virulent
virus [151–154]. Rabies virus attenuation was first validated by experiments which Pasteur and his
team reported in 1884, documenting survival of dogs vaccinated by live, attenuated vaccine before
viral challenge. The prototypal vaccine against rabies was first used as salvage therapy in humans
presenting signs of declared clinical rabies, with rapid documented failure in at least one instance:
that of the child Antoinette Poughon in late June 1885 [92,155]. The vaccine, however, was to meet
resounding success in patients exposed to rabies virus but with yet no signs of declared infection.
History remembers a 9-year-old schoolboy, Joseph Meister (Figure 6), attacked and bitten
14 times by Mr. Théodore Vonné’s dog while on an errand in Maisonsgoutte (Meissengott), in then
German-occupied Alsace, on 4 July 1885 [152]. Joseph Meister suffered deep bites to the right hand
and to the thighs and leg. The owner of the dog, Mr. Théodore Vonné (or Vone) also received one bite
to the arm by the same dog before it was shot by the police; the bite being delivered through cloth
(untorn) and leaving no wound, Mr. Vonné received no prophylaxis and survived [72,154,156,157].
Dr. EugèneWeber, a local medical doctor with a practice in nearby Villé, made a call to theMeister home
that evening and cleansed the wound thoroughly with carbolic acid, 12 h after the attack [158]. As he
waited in a café for the coach to return home, Vonné spoke of the event with clients and was told that
Pasteur had developed prevention against rabies [158]. He went back to the Meister home to inform
the family and Meister, accompanied by his mother and Vonné left the next morning by train and
arrived in Paris on 6 July. Although a medical doctor, Emile Roux did not inject the vaccine into Meister.
This may be because he was not regularly working in the laboratory at the time or had not practiced
medicine for too long, but published sources agree it clearly was because Roux had unequivocally
stated his concern that the rabies vaccination procedure developed in dogs was insufficiently tested
and too risky to be used in humans [92,131,159,160]. Jacques-Joseph Grancher therefore administered
subcutaneously the first doses of live attenuated rabies vaccine on 6 July 1885, at 8:00 PM in the
presence of Louis Pasteur—who, as a chemist, was not authorized to perform injections—and Alfred
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Vulpian. The first injection was derived from the chord of an inoculated rabbit which died of rabies on
21 June (15 days earlier) [92]. Over the 10 following days, Joseph Meister received 12 additional doses
of attenuated and progressively more virulent virus to quickly generate an immune response, in an
attempt to beat the virus in a deadly race against time [19,33,72]. Meister survived.Trop. Med. Infect. Dis. 2017, 2, 5  9 of 21 
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Figure 6. Joseph Meister in 1885, the first human to have received Pasteur’s live, attenuated rabies
vaccine on July 6, 1885 (© Institut Pasteur-Musée Pasteur).
This successful attempt was repeated in late October 1885 in a second case, that of a 15-year-old
shepherd, Jean-Baptiste Jupille from Villers-Farlay, Jura, who sustained on October 14 a deep bite to
the left and right hands after an attack by a furious dog [92,152]. Jupille was referred to Pasteur by the
town mayor and received rabies post-exposure prophylaxis (PEP) in Paris from 20 to 30 October, 1885.
Following Grancher’s accidental exposure to the attenuated vaccine during Jupille’s PEP, Adrien Loir
and Eugène Viala became the two first humans to receive pre-exposure rabies vaccination [134].
Having become a laboratory assistant in the Pasteur team, Meister was also the first to receive rabies
vaccine boosters when he underwent a—reportedly less well-tolerated—second PEP in 1890 after being
bitten by a guinea pig with experimental rabies (M-T. Meister, personal communication, 16 May 2016).
For the very first time since its first recorded description 3800 years earlier, and despite some
failures due mostly to delayed referral [92,154], clinicians now had a proven and effective means of
rabies prevention in humans. This led to Louis Pasteur’s laboratory at École Normale Supérieure,
Paris routinely offering PEP services. Around one year after the first PEP, L. Pasteur in August 1886
reported 3 (0.2%) deaths (whether the case of Louise Pelletier is included among these deaths is
unclear) among 1235 PEP recipients [92], while another source speaks of 21 (1.0%) deaths among 1986
recipients (including one from Bombay, India) by 22 August of that same year [161]. In 1887, Vulpian
documented 12 (0.7%) deaths among 1726 PEP recipients, for an expected number of approximately
264 (15.3%) rabies deaths if PEP had not been administered [162].
The rabbit cord used in the Pasteur vaccination protocol was known to preserve its virulence
despite preservation in carbolic acid [152]. It was, however, not stabilized and therefore not usable
outside Paris unless “transported” by/in inoculated rabbits. Patients therefore had to travel to
access PEP, in some cases across continents or oceans [163,164]. After PEP spared the lives of 16 of
19 Russian patients who came to Paris from Smolensk after being attacked by a rabid wolf [165],
Elie Metchnikoff was named director of the first center established specifically to produce rabies
vaccine (which benefited from Louis Pasteur’s support) and implemented the “Pasteur treatment” in
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Odessa in June 1886, [166–168]. The not-for-profit, non-governmental Institut Pasteur Foundation was
incorporated in France by a decree on 4 June 1887. The Institut Pasteur itself was built and inaugurated
on 14 November 1888, after an unprecedented national and international movement and fundraising
campaign to further disseminate the technique and to pursue research [19,118,163].
6. Modern Developments
Over the decades that followed the development of PEP by Pasteur and his team, many rabies
prevention centers or “Pasteur institutes”—some affiliated with the Institut Pasteur in Paris, most
not [167]—appeared across the Old and the NewWorld. In 1909 there were 75 such centers worldwide,
including in then Indochina [72,169]. These centers cultured in vivo then attenuated highly virulent
rabies virus (RABV) locally. In Saigon, animal bite victims received PEP as early as 1891, becoming the
first to receive rabies PEP in Asia, Africa or Latin America (Figure 7) [170–174]. This was facilitated by
RABV preservation techniques in glycerin, also developed by Emile Roux and Albert Calmette [30,118],
which no longer made uninterrupted sequences of RABV inoculation to successive unfortunate rabbits
every ten days a requirement to preserve live virus.
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Post-exposure prophylaxis biologicals and procedures were improved in the ensuing decades.
The rabies vaccine was further refined by Emile Roux [170,175], Victor Babes [72], Follen Cabot [176],
Claudio Fermi, Endre Högyes [177] and especially David Semple [177–179]. Babes andM. Lepp in 1889
first described immunity as a correlate of vaccine response and protection, discussed inactivated rabies
vaccines and experimentally demonstrated protection of animals by antiserum in 1891 [72,177,180].
Solutions of attenuated virus mixed with serum immunoglobulin were experimented at the Pasteur
Institute as early as 1902 [169]. Rabies antiserum was administered in humans to interrupt replication
of the virus in bite wounds by Fermi in 1911 and the use of rabies-specific immunoglobulin was
generalized in the 1950s [31,181–186]. Monoclonal antibodies (produced either in animals or by
yeasts or plants) are now being developed to replace unaffordable equine—let alone human—rabies
immunoglobulin (RIG), so far with mixed but promising results [187–194].
Semple’s killed-virus vaccine, developed in 1911 at the Pasteur Institute in Kasauli, India, using
sheep brain tissue, remained the most used worldwide into the 2000s. Although the vaccine had
limited immunogenicity and required a tedious protocol (and was painful, as experienced first-hand
by the author in West Africa as a child in the 1970s) it was affordable and for decades saved countless
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human lives, especially in the developing world. The League of Nations’ health organization’s bulletin
reported 115,859 PEP worldwide recipients in 1932-May 1934 among whom 439 (0.4%) were considered
to have died of rabies [195]. After initial attempts at the Institut Pasteur in 1913 [196], the rabies virus
was successfully cultured in vitro through several passages in 1936 [197]. In the 1960s, harvests of
RABV grown in tissue cultures became increasingly pure [198] and normative methods were developed
to standardize the potency of the various vaccines [31,199,200]. Vaccines were developed on suckling
mouse brains [201] or on duck or chicken embryos [202], until the advent of new, highly antigenic,
better-tolerated cell-culture vaccines [33,203–206]. This allowed for the tedious Pasteur then Semple
protocols to be progressively replaced by the shorter Essen and Zagreb protocols [207]. An oral vaccine
was developed for wildlife in 1971 [208]. Through canine population regulations and control, rabies
was eliminated from cities in the industrialized world and elsewhere, including Shanghai in 1949 and
Malaya in the early 1950s [25,209].
Research on the rabies virus itself made rapid advances. In 1903, Adelchi Negri described the
first RABV-neuron interaction and Lina Luzzani-Negri described its diagnostic value in infection with
“street” rabies virus [210–212]. The rabies virus itself was first observed by electron microscope in the
early 1960s [213–215]. The molecules produced by RABV (transcriptional mapping) were described
in 1978 [216] and the viral genes which code for them were sequenced in their entirety in 1988 [217].
Direct and indirect diagnostic methods were developed to reliably confirm infection and antibody
protection [200,218,219].
These advances led to the validation of rabies vaccine effectiveness, of shorter and dose-sparing
regimens and of the equivalence of the intradermal vaccination route [220–222]. It also enabled the
identification of nonfatal cases of RABV infection in animals [223–226] and in humans [227–229].
Human survivors of clinical rabies were first documented, mostly in the New World following bat
exposure [230–236].
Whether or not these survived thanks to attempted treatment remains hotly debated [33,237–239].
Despite our dramatic advancements in the knowledge and prevention of rabies, and with a handful of
exceptions to date [229], all documented patients with clinically-declared rabies have died within a
few hours or days. Efforts to test some traditional medicines, in Ethiopia for example, have failed [240].
Antivirals are currently being explored as a therapeutic resource, so far with little success [241].
7. Conclusions
Our understanding of the mechanisms and primary and secondary prevention of rabies in animals
and in humans has profoundly changed since the Laws of Eshnunna were introduced by one of the
earliest known civilizations. Yet despite this, and great progress in symptomatic management of
encephalitic patients, clinicians caring for animals or patients with symptomatic rabies remain as
powerless today as they were 4000 years ago. Rabies remains today the most lethal disease known to
man and this author is not aware of any other disease for which—once the disease is declared—modern
medicine has offered no tangible improvement. We wait in hope for researchers to identify antiviral
agents capable of controlling progression of clinically-declared rabies.
Rabies became a neglected disease when it was eliminated from Europe and North America. It is
emerging in some island territories and remains uncontrolled in most of the developing world, where
surveillance of dog bites, rabies exposures (syndromic or laboratory-confirmed) or rabies deaths, is
poor [242,243]. The prevention of human rabies deaths in the 21stC still rests on tools and strategies
developed in the 19thC: Effective primary prevention of animal bites and responsible dog ownership
as delineated by Fleming (in 1872) [28]; canine vaccination as proposed by H. Bouley (in 1884) [72] and
timely and effective rabies post-exposure prophylaxis (developed by Pasteur and his team and first
administered in 1885).
An estimated total of 59,000 humans die of rabies each year, more than twice the estimated
28,600 deaths caused by the tragic 2014–2016 Ebola outbreak in West Africa [244,245]. The World
Health Organization, the World Organization for Animal Health and the Food and Agriculture
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Organization of the United Nations are currently spearheading an effort to eliminate dog-transmitted
rabies worldwide by 2030 [246]. While we strive for all dogs to be vaccinated, a major effort is urgently
needed to make the time-proven and well-tolerated vaccine (and immunoglobulin) geographically
and financially accessible in a timely way to those people who remain the most vulnerable to rabies:
the rural populations of developing countries [247,248].
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